Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

Papakostas GI, Fava M.

Eur Neuropsychopharmacol. 2009 Jan;19(1):34-40. doi: 10.1016/j.euroneuro.2008.08.009. Epub 2008 Sep 26. Review.

PMID:
18823760
[PubMed - indexed for MEDLINE]
2.
3.

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL.

J Clin Psychiatry. 2010 Mar;71(3):270-9. doi: 10.4088/JCP.08r04516blu. Epub 2010 Jan 26. Review.

PMID:
20122371
[PubMed - indexed for MEDLINE]
4.

Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach.

Tedeschini E, Fava M, Papakostas GI.

J Clin Psychiatry. 2011 Jan;72(1):98-113. doi: 10.4088/JCP.09m05725blu. Epub 2010 Nov 2. Review.

PMID:
21208576
[PubMed - indexed for MEDLINE]
5.

Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.

Iovieno N, Papakostas GI.

J Clin Psychiatry. 2012 Oct;73(10):1300-6. doi: 10.4088/JCP.11r07485. Review.

PMID:
23140647
[PubMed - indexed for MEDLINE]
6.

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.

Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC.

Biol Psychiatry. 2007 Dec 1;62(11):1217-27. Epub 2007 Jun 22. Review.

PMID:
17588546
[PubMed - indexed for MEDLINE]
7.

Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials.

Iovieno N, Tedeschini E, Ameral VE, Rigatelli M, Papakostas GI.

Int Clin Psychopharmacol. 2011 Mar;26(2):69-74. doi: 10.1097/YIC.0b013e328340775e. Review.

PMID:
20962663
[PubMed - indexed for MEDLINE]
8.

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.

Int J Clin Pract. 2007 Aug;61(8):1337-48. Review.

PMID:
17627710
[PubMed - indexed for MEDLINE]
9.

Placebo response in studies of major depression: variable, substantial, and growing.

Walsh BT, Seidman SN, Sysko R, Gould M.

JAMA. 2002 Apr 10;287(14):1840-7. Review.

PMID:
11939870
[PubMed - indexed for MEDLINE]
10.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
[PubMed - indexed for MEDLINE]
11.

Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.

Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA.

Am J Psychiatry. 2009 Jan;166(1):42-9. doi: 10.1176/appi.ajp.2008.08020247. Epub 2008 Dec 1. Review.

PMID:
19047322
[PubMed - indexed for MEDLINE]
12.

Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram.

Stein DJ, Baldwin DS, Dolberg OT, Despiegel N, Bandelow B.

J Clin Psychiatry. 2006 Nov;67(11):1741-6. Review.

PMID:
17196054
[PubMed - indexed for MEDLINE]
13.

Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis.

Posternak MA, Zimmerman M.

Br J Psychiatry. 2007 Apr;190:287-92. Review.

PMID:
17401033
[PubMed - indexed for MEDLINE]
Free Article
14.

Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders.

Cohen D, Consoli A, Bodeau N, Purper-Ouakil D, Deniau E, Guile JM, Donnelly C.

J Child Adolesc Psychopharmacol. 2010 Feb;20(1):39-47. doi: 10.1089/cap.2009.0047. Review.

PMID:
20166795
[PubMed - indexed for MEDLINE]
15.

Treating each and every depressed patient.

Kennedy SH.

J Psychopharmacol. 2008 Sep;22(7 Suppl):19-23. doi: 10.1177/0269881108093270. Review.

PMID:
18753279
[PubMed - indexed for MEDLINE]
16.

Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.

Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, Lerer B, Fava M.

Int Clin Psychopharmacol. 2009 Jan;24(1):19-25. doi: 10.1097/YIC.0b013e328314dfaf. Review.

PMID:
19092448
[PubMed - indexed for MEDLINE]
17.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
[PubMed - indexed for MEDLINE]
18.

Impact of medical comorbid disease on antidepressant treatment of major depressive disorder.

Iosifescu DV, Bankier B, Fava M.

Curr Psychiatry Rep. 2004 Jun;6(3):193-201. Review.

PMID:
15142472
[PubMed - indexed for MEDLINE]
19.

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database.

Baldwin DS, Stein DJ, Dolberg OT, Bandelow B.

Hum Psychopharmacol. 2009 Jun;24(4):269-75. doi: 10.1002/hup.1019. Review.

PMID:
19334042
[PubMed - indexed for MEDLINE]
20.

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials.

Faries DE, Heiligenstein JH, Tollefson GD, Potter WZ.

J Clin Psychopharmacol. 2001 Dec;21(6):561-8. Review.

PMID:
11763002
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk